HIV vaccine efficacy study begins in South Africa
The new trial, to be conducted at 15 sites across South Africa, where more than 1,000 people become infected with HIV every day, aims to test whether it will provide greater and more sustained protection than the RV144 regimen.
Nov 29, 2016, 06:56 AM IST